These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13861239)

  • 21. Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria.
    Blau K; Summer GK; Newsome HC; Edwards CH
    Clin Chim Acta; 1973 May; 45(3):197-205. PubMed ID: 4708049
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia.
    Potkin SG; Cannon-Spoor HE; DeLisi LE; Neckers LM; Wyatt RJ
    Arch Gen Psychiatry; 1983 Jul; 40(7):749-52. PubMed ID: 6860076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A note on the effect of phenylalanine on the blood sugar in phenylketonuria.
    PARTINGTON MW
    J Ment Defic Res; 1961 Jun; 5():1-3. PubMed ID: 13733037
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of heterozygote carrier state of phenylketonuria gene].
    D'iachkova AIa; Lebedev BV
    Pediatriia; 1969 Aug; 48(8):50-3. PubMed ID: 5354560
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenylketonuria: the phenylalanine-tyrosine ratio in the detection of the heterozygous carrier.
    HSIA DY
    J Ment Defic Res; 1958 Jun; 2(1):8-16. PubMed ID: 13576048
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of phenylketonuric heterozygotes.
    Jackson SH; Hanley WB; Gero T; Gosse GD
    Clin Chem; 1971 Jun; 17(6):538-43. PubMed ID: 5103385
    [No Abstract]   [Full Text] [Related]  

  • 27. The factor analytic, logarithmic and optimum solutions in separating heterozygous carriers and normal control subjects in phenylketonuria.
    Kääriäinen R
    Hereditas; 1973; 75(2):241-9. PubMed ID: 4782045
    [No Abstract]   [Full Text] [Related]  

  • 28. Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia.
    Ford RC; Berman JL
    Lancet; 1977 Apr; 1(8015):767-71. PubMed ID: 66568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylketonuria heterozygote detection in families with affected children.
    Paul TD; Brandt IK; Elsas LJ; Jackson CE; Mamunes P; Nance CS; Nance WE
    Am J Hum Genet; 1978 May; 30(3):293-301. PubMed ID: 677126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Method of detection of heterozygotic carrier state in phenylketonuria].
    Baikov AD; Sitnichenko EI
    Lab Delo; 1973; 5():293-5. PubMed ID: 4129158
    [No Abstract]   [Full Text] [Related]  

  • 31. Linkage analysis using heterozygote detection in phenylketonuria.
    Paul TD; Brandt IK; Elsas LJ; Jackson CE; Nance CS; Nance WE
    Clin Genet; 1979 Oct; 16(4):217-32. PubMed ID: 519892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminant analysis for detection of phenylketonuric heterozygotes.
    Christian BG
    Soc Biol; 1971 Mar; 18(1):64-72. PubMed ID: 5580588
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenylketonuria: a linkage study using phenylalanine tolerance tests.
    RENWICK JH; LAWLER SD; COWIE VA
    Am J Hum Genet; 1960 Sep; 12(3):287-322. PubMed ID: 14437398
    [No Abstract]   [Full Text] [Related]  

  • 34. Discrimination of heterozygotes for phenylketonuria, persistent hyperphenylalaninemia and controls by phenylalanine loading.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1986 Dec; 161(3):347-52. PubMed ID: 3802540
    [No Abstract]   [Full Text] [Related]  

  • 35. Heterozygous carriers in the relatives of a case of phenylketonuria.
    Kääriäinen R; Karlsson R
    Hereditas; 1973; 75(1):109-17. PubMed ID: 4778101
    [No Abstract]   [Full Text] [Related]  

  • 36. [Phenylalanine level in the serum of heterozygotes for phenylketonuria under intensified protein catabolism].
    Bliumina MG
    Genetika; 1981; 17(5):910-4. PubMed ID: 7195856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in the identification of the heterozygote in phenylketonuria.
    Lehmann WD
    J Pediatr; 1989 Jun; 114(6):915-24. PubMed ID: 2566668
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for PKU heterozygosity in bipolar affectively ill patients.
    Targum SD; Gershon ES; Shen RS; Abell CW
    Biol Psychiatry; 1979 Aug; 14(4):651-5. PubMed ID: 486619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical evaluation of a new method to detect carriers of phenylketonuria.
    Minami R; Olek K; Wardenbach P
    Humangenetik; 1975 Sep; 29(2):151-4. PubMed ID: 1236833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carrier screening for phenylketonuria: comparison of two discriminant analysis procedures.
    Freehauf CL; Lezotte D; Goodman SI; McCabe ER
    Am J Hum Genet; 1984 Nov; 36(6):1180-9. PubMed ID: 6517048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.